2011 Issues   /   September 2011

Neurotransmitter Discovery Could Lead To Treatments for Mental Disorders

USM By U.S. Medicine
September 26, 2011

For years, researchers have been working to discover which cellular processes allow humans to learn and store memories, and how these processes are compromised by diseases such as schizophrenia and Alzheimer’s. Researchers at NIH say they believe they have uncovered one piece to this puzzle.

Neurons in the brain communicate with one another through the use of neurotransmitters — chemicals which stimulate electrical signals in neighboring neurons. Studies in mice have shown that the timing of when the neurotransmitter acetylcholine is released into the hippocampus may play a key role in regulating synaptic strength.

Researchers Jerrel Yakel, PhD, and Zhenglin Gu, PhD — investigators in the National Institute of Environmental Health Sciences (NIEHS) — developed a study group of mice whose neurons produced a light-sensitive protein. They were then able to use a laser to stimulate these neurons to release acetylcholine.

They were able to demonstrate that, when the neurons were stimulated to release acetylcholine at just the right time in the hippocampus, they could induce a cellular change in synapses that use glutamate. Glutamate, another neurotransmitter, has been found to be key in learning and memory and in long-term potentiation — a long-lasting enhancement in signal transmission between neurons.

The NIEHS research team found that timing was crucial and that even a few hundredths of a second in the timing of the acetylcholine release could affect how adjacent neurons responded. A difference as small as 20 milliseconds in the timing of the laser could result in very different reactions.

According to Yakel, these findings might represent a first step in studying disorders that affect learning and memory, such as schizophrenia and Alzheimer’s. People with Alzheimer’s have been shown to have low levels of acetylcholine in the cerebral cortex. A similar deficit has been shown among patients with schizophrenia, with acetylcholine depletion being linked to visual hallucination in schizophrenic patients.

1: Gu Z, Yakel JL. Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity.Neuron. 2011 Jul 14;71(1):155-65. PubMed PMID: 21745645; PubMed Central PMCID: PMC3134790.


Related Articles

Mental Health Diagnoses Increase Coronary Artery Disease Risks in Women Veterans

BOSTON — Depression and anxiety can be debilitating on their own. For women veterans, the conditions raise an additional concern: They significantly increase the risk of coronary artery disease (CAD)—the leading cause of death in the United States.

For Memory Issues, It’s Not So Much the Concussion as the Blast

BOSTON—Many more servicemembers might have been injured by blasts in Iraq and Afghanistan than previously reported.


U.S. Medicine Recommends


More From psychiatry

Psychiatry

VA Study Addresses Concerns About Anti-Epileptic Drugs, Suicidal Behavior Link

In 2008, the U.S. Food and Drug Administration issued an alert about increased risk for suicidal ideation and behavior for patients taking anti-epileptic drugs (AEDs).

Psychiatry

MHS Implements Multiple Programs to Improve PTSD and Depression Care

In the year since the release of a RAND report critical of follow-up within the Military Health System (MHS) for patients with post-traumatic stress disorder (PTSD) and depression, the DoD has released results of several new programs to improve screening, increase the number of therapeutic visits and track mental health measures.

Psychiatry

Most Post-9/11 Veterans Report Doing Well at Work and at Home

BOSTON – The overwhelming majority of veterans of U.S. conflicts since the terrorist attack on 9/11/2001 are nothing like the post-traumatic stress disorder (PTSD)-addled, homeless opioid-addicts too often depicted in the media and in political campaigns.

Psychiatry

Telehealth Device Helps Avoid Suicide in Veterans With Schizophrenia

Telehealth tools are showing promise in helping save the lives of schizophrenic veterans with a high risk of suicide, but the VA is facing a setback in using them.

Psychiatry

Can Gene Analysis Improve the Treatment of Schizophrenia in Veterans?

Antipsychotics play a major role in the treatment of schizophrenia, but their efficacy and tolerability in individual patients varies widely.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up